CD8A and Alzheimer disease: In our study, CD8+ TEMRAs, previously linked to AD-related cognitive decline defined by CSF AD-biomarkers, cognition, and imaging [5–7], correlate with plasma biomarkers of brain injury (Nf-L and GFAP).